Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2014
03/27/2014US20140088100 Inhibitors of the fibroblast growth factor receptor
03/27/2014US20140088098 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS
03/27/2014US20140088097 Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
03/27/2014US20140088086 Compounds and methods for treatment of hypertension
03/27/2014US20140088084 Oxazine derivatives and their use in the treatment of neurological disorders
03/27/2014US20140088080 Imidazopyridine compounds
03/27/2014US20140088076 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
03/27/2014US20140088075 Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
03/27/2014US20140088070 Nitrogen containing compounds and their use
03/27/2014US20140088068 1,6-Diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
03/27/2014US20140086870 Pyrazole derivatives as jak inhibitors
03/26/2014EP2711361A1 Nitrogenated heterocyclic compound and agricultural or horticultural fungicide
03/26/2014EP2710003A1 Fused bicyclic kinase inhibitors
03/26/2014EP2709997A1 Inhibitors of bruton's tyrosine kinase
03/26/2014EP2709996A1 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
03/26/2014EP2709984A1 New hexahydrocyclopentapyrrolone, hexahydropyrrolopyrrolone, octahydropyrrolopyridinone and octahydropyridinone compounds
03/26/2014EP2709451A1 N-linked lactam m1 receptor positive allosteric modulators
03/26/2014CN103687852A 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as vegf receptor kinase inhibitors
03/26/2014CN103682169A Bipolar body material
03/26/2014CN103665004A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664996A Indole derivative and preparation method thereof
03/26/2014CN103664974A Aryl [a] indole [2,3-g] quinolizine compound as well as preparation method, pharmaceutical composition and application thereof
03/26/2014CN103664942A Method for extracting matrine by coupling molecular imprinting with ultrasonic extraction
03/26/2014CN103664941A Preparation method of vinpocetine analogue
03/26/2014CN103664940A Preparation method of moxifloxacin impurity
03/26/2014CN103664939A Synthesis method of pyraclonil
03/26/2014CN103664938A Benzopyrimidine-containing SYK inhibitor
03/26/2014CN103664937A Quinolyl[7,8-h]quinoline compounds and application thereof
03/26/2014CN103664936A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664935A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664903A Benzoazepine compounds and preparation method and application thereof
03/26/2014CN103664895A Pyridazinone compounds, preparation method thereof, medicinal composition and application thereof
03/26/2014CN103664800A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664799A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664798A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN103664748A Pyrene compound and organic light emitting diode device including the same
03/26/2014CN103664737A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664734A Heterocyclic hydroxamic acid compound as well as pharmaceutical composition and application thereof
03/26/2014CN102731497B Method for preparing paichongding
03/26/2014CN102604412B Bis-carbazole group containing dye for dye-sensitized solar cells and preparation method of bis-carbazole group containing dye
03/26/2014CN102344464B High water-solubility ruthenium metal complex singlet oxygen fluorescent probe, preparation method thereof, and application thereof
03/26/2014CN102015708B Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
03/25/2014US8680275 Fused heterocyclic compounds as orexin receptor modulators
03/25/2014US8680111 Macrocyclic derivatives for the treatment of diseases
03/25/2014US8680107 Activators and therapeutic applications thereof
03/25/2014US8680104 Piperazinylpiperidine derivatives as chemokine receptor antagonists
03/25/2014US8680099 6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders
03/25/2014US8680098 Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
03/25/2014US8680096 Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
03/25/2014US8680089 Fused pyridine derivatives
03/25/2014US8680079 Tetrahydro-imidazo [1,5-A] pyridyin derivatives as aldosterone synthase inhibitors
03/25/2014CA2630617C Compositions and methods for modulating gated ion channels
03/25/2014CA2604463C 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
03/25/2014CA2547020C 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
03/20/2014WO2014043068A1 Glucosylceramide synthase inhibitors
03/20/2014WO2014042263A1 Novel renin inhibitor
03/20/2014WO2014042163A1 Novel compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device
03/20/2014WO2014041131A1 Tricyclic quinoline and quinoxaline derivatives
03/20/2014WO2014041125A1 Specific inhibitors of protein p21 as therapeutic agents
03/20/2014WO2014040969A1 2-oxo-2,3-dihydro-indoles for the treatment of cns disorders
03/20/2014WO2014040549A1 Alkynyl heteroaromatic ring compound and application thereof
03/20/2014WO2014040373A1 Pi3k and/or mtor inhibitor
03/20/2014WO2014013507A4 A process for the preparation of tunable fluorescent polymer composition
03/20/2014US20140080862 Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
03/20/2014US20140080861 Heterocyclic compounds iwth affinity to muscarinic receptors
03/20/2014US20140080859 Bis-Quaternary Ammonium Cyclophane Compounds that Interact with Neuronal Nicotinic Acetylcholine Receptors
03/20/2014US20140080853 Compounds and Formulations Suitable for Radical Scavenging
03/20/2014US20140080827 Novel kinase modulators
03/20/2014US20140080823 Spirocyclic derivatives as histone deacetylase inhibitors
03/20/2014US20140080822 Tricyclic Pyrazole Sulphonamide Compounds and Methods of Making and Using Same
03/20/2014US20140080816 Tricyclic quinoline and quinoxaline derivatives
03/20/2014US20140080814 Tricyclic quinoline and quinoxaline derivatives
03/20/2014US20140080813 Tricyclic quinoline and quinoxaline derivatives
03/20/2014US20140080810 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
03/20/2014US20140080805 Pyrrolidine inhibitors of iap
03/20/2014US20140080802 Inhibitors of Histone Deacetylase
03/20/2014US20140080801 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/20/2014US20140080756 2,3-dihydro-1h-inden-1-yl-2,7-diazaspiro[3.5]nonane derivatives
03/20/2014US20140077175 Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/19/2014EP2707367A1 Methods for preparing naphthyridines
03/19/2014CN103649088A 1,6- diazabicyclo [3,2,1] octan- 7 - one derivatives and their use in the treatment of bacterial infections
03/19/2014CN103649087A Substituted imidazopyridines and intermediates thereof
03/19/2014CN103649086A Methods for preparing naphthyridines
03/19/2014CN103649085A Pyridin-2(1h)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
03/19/2014CN103649079A Hepatitis C inhibitors and uses thereof
03/19/2014CN103649077A Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103649074A Substituted azaheterocycles for the treatment of cancer
03/19/2014CN103649051A Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1, 6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof
03/19/2014CN103642299A Application of benzoheterocycle alkaloids in preparation of marine organism stain preventing coatings
03/19/2014CN103641835A AZapyrenes For Electronic Applications
03/19/2014CN103641833A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103641832A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/19/2014CN103641831A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/19/2014CN103641830A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/19/2014CN103641828A Triazolonaphthyridine-one derivative compound and preparation method and application thereof
03/19/2014CN103641827A Purrocoline derivative and synthetic method and application thereof
03/19/2014CN103641816A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103638884A Process improved system for producing praziquantel
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 646